Tagged with Up

Germany Some of the top recent stories from Germany, Europe’s leading pharma market according to CPhI, including big new investments from Merck and Bayer, the implications of the country’s new Digital Healthcare Act, the impact of the coronavirus outbreak on investor sentiment, and the health minister potentially poised to become Germany’s…

Mexico Below is a selection of top recent news from Mexican pharma and healthcare, including the healthcare reforms president Andres Manuel Lopez Obrador is prioritising, latest news on the INSABI program, cancer research, and the lack of coronavirus expertise in Mexico.   Zero tolerance for corruption: the Mexican pharma sector must…

Hungary Hungary’s longstanding tradition of pharmacology is a major point of pride for the country’s scientists and researchers who today have hopes to elevate the country’s research environment to a region-leading position once more through new models of industry-academia collaboration.   Strength in CNS Hungary has a very strong tradition in…

India Below is a selection of the top stories in Indian pharma from recent months, ranging from efforts to counter the coronavirus, to regulatory reform, the spike in USFDA warning letters to Indian pharma manufacturers, promising export markets, and the growth of the Indian domestic market.   Repurposing HIV drugs to…

Hungary Péter Ferdinandy and Zsuzsanna Helyes, President and Secretary General of the Hungarian Society for Experimental and Clinical Pharmacology (HUPHAR), share their insights about the role of the society, the R&D capabilities of the Hungarian pharmaceutical industry, the ability of local players to bring innovations to the market, and the future…

Puerto Rico Puerto Rico’s export-driven economy could not exist without someone moving, literally, things from point A to point B. As the US Caribbean territory remains one of the world’s premiere manufacturing hubs, accounting for 22 percent of total US exports of pharmaceutical and medicine manufacturing in 2018, according to the US…

Russia Russia is facing a drug shortage crisis which is having a particular impact on patients with life-threatening conditions. A combination of geopolitical and bureaucratic issues are restricting the flow of medications to the patients who need them the most.   An alarming shortage of medicines in Russia is driving some…

4+7 China’s roll-out of a 25-province expansion to the 4+7 pilot procurement scheme has seen pharma companies scrambling to cut prices for their drugs even further in the latest bidding war.   Pharma companies in China are facing yet another intense race to the bottom on pricing. On the 24th of…

China Kirsch Pharma is a raw materials provider to the pharmaceutical, nutritional, biotechnology, veterinary and cosmetic industries. The business in China was established in 1997, importing high-quality raw materials from Germany. Kirsch China’s Fabian Bieletzki introduces the affiliate’s current areas of focus, the cultural differences between Europe and China and how…

Taiwan Dr. Wen-cherng Tsai, founder and chairman of SuperLab, explains the company’s unique business model as the only third-party fair testing organization and pre-clinical CRO across the medical, chemical and biological related fields. Dr. Tsai goes on to highlight SuperLab’s competitive offering and top-tier accreditation as a premier service partner in…

Puerto Rico Dr Agustín Rullán, the newly appointed chancellor of the University of Puerto Rico Mayagüez (UPRM) and former dean of the university’s College of Engineering, outlines the main priorities in his new position. He highlights the need for strong collaboration between academia and industry and the progress UPRM has made working…

Sweden Eric Wahlberg, CEO of Uppsala University Hospital, Sweden´s oldest university hospital, explains his strategic vision of hospital management and how Uppsala is utilising e-health, precision medicine, clinical trials, small biotech companies and the use of IT systems in hospitals.   I understand how doctors and nurses think, and what their…